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1. INTRODUCTION 
            Ever since the birth of mankind there has been a relationship between life, disease and 
plants. Primitive men started studying diseases and treatments and there is no record that they 
used synthetic medicines for ailments. They started using plants and this knowledge of herbal 
remedies was transferred to generations as folk medicine. So the history of herbal medicine is 
as old as human history.  
            The traditional medicine refers to a broad range of ancient and natural health care 
practices including tribal practices as well as Ayurveda, Siddha and Unani. It is estimated that 
more than 7500 plants are used mostly in rural and tribal villages of India.1 The turnover of 
herbal medicine “over the counter” ethical and classical formulations and home remedies of 
Ayurveda, Siddha and Unani systems of medicine  is about $1 billion and the export of herbal 
crude extracts is about $80 million.2 
            The WHO has defined traditional medicine (including herbal drugs) as “comprising 
therapeutic practices that have been in existence, often for hundreds of years before 
development and spread of modern medicine and are still in use today.”2 The traditional 
preparations comprise of medicinal plants, minerals, organic matter, etc. herbal drugs 
constitute only those traditional medicines which primarily use medicinal plant preparations 
for therapy. 
            Herbal medicines are in great demand in the developed world due to their efficacy, 
safety and lesser side effects. These drugs are made from renewable resources of raw 
materials by eco-friendly and bio-friendly processes and bring economic prosperity.  The 
chemical constituents present in them are a part of the physiological functions of living flora 
and hence they are believed to have better compatibility with the human body. Ancient 
literature also mentions herbal medicines for age several diseases namely memory loss, 
osteoporosis, diabetic wounds, immune and liver disorders. 3  
            Along with the major health complications such as cancer, cardiovascular, respiratory 
diseases, the incidence of liver disease is also on the rise along with the growing population. 
It is a major cause of death still increasing every year and it is the fifth big killer in countries 
such as England and Wales. The survey report says that 16,087 people in the UK died from 
liver disease in 2008, a 4.5% increase since 2007.4 Liver disease deaths have increased by 
12% in just three years, since 2005.5 According to the latest WHO data published in April 
                                                                                                          Introduction 
 
Department of Pharmacognosy, COP, MMC. Page 2 
 
2011, in India deaths associated with liver disease reached 208,185 or 2.31% of total deaths. 
The age adjusted death rate is 23.59 per 100,000 of population and India ranks #27 in the 
world.  Worldwide, the estimated annual incidence rate of drug-induced liver injury is 13.9 -
24 per 100,000 inhabitants. 
           The major functions of the body such as metabolism and excretion of xenobiotics are 
carried out by liver. Hence, the liver is vulnerable to a wide variety of metabolic, circulatory 
and neoplastic insults. The primary diseases of liver are viral hepatitis, alcoholic liver disease, 
non-alcoholic fatty liver disease and hepato-cellular carcinoma. Hepatic damage also occurs 
secondary to some of the most common diseases in humans, such as cardiac decomposition, 
disseminated cancer and extrahepatic infections.6 
 
Causes of liver injury 6,7 
 Chemical induced: Carbon tetrachloride, alcohol consumption, aflatoxins, 1,1,2,2- 
tetrachloroethane, carbon tetrabromide, acetylene tetrabromide, dimethyl formamide, 
ethylene dichloride. 
 Drug-induced: More than 900 drugs have been implicated in causing liver injury and 
it is the most common reason for a drug to be withdrawn from the market. Drug 
induced liver injury is responsible for 5% of hospitalised persons and 50% of all acute 
liver failures. Some of them are Acetaminophen overdose, anti-tubercular drugs, 
chemotherapeutic agents, thioacetamide. 
 Virus induced: Hepatitis A, B, C, D, E. 
 Other causes: Non-alcoholic fatty liver, malnutrition, extrahepatic infections, 
ingestion of poisonous wild mushrooms, haemochromatosis (an inherited disorder that 
causes body to absorb and store iron too much). 
 
Mechanism of liver damage:7,8 
             75% of blood coming to the liver arrives directly from gastrointestinal organs and 
then spleen via portal veins that bring drugs and xenobiotics in near-undiluted form. Several 
mechanisms are responsible for either inducing hepatic injury or worsening the damage 
process. Many chemicals damage mitochondria, an intracellular organelle, that produces 
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energy. Its dysfunction releases excessive amount of oxidants that, in turn, injure hepatic 
cells. Activation of enzymes in the cytochrome P-450 system such as CYP2E1 also leads to 
oxidative stress. Injury to hepatocyte and bile duct cells lead to accumulation of bile acid 
inside the liver. This promotes further liver damage. Non-parenchymal cells such as Kupffer 
cells, fat storing stellate cells and leukocytes (neutrophils and monocyte) also have a role in 
mechanism. 
Patterns of liver injury6 
         The liver has a limited cellular and tissue responses to injury, regardless of the cause. 
They are: 
 Hepatocyte degeneration and intracellular accumulations 
 Hepatocyte  necrosis and apoptosis  
 Inflammation  
 Regeneration 
 Fibrosis  
 
Diagnosis  
Liver disease is an insidious process in which clinical detection and symptoms of hepatic 
damage may occur weeks or months after the onset of injury. Hence it is detectable only by 
abnormal laboratory tests.6 
 
Treatment  
Importance of Herbs in treating liver disorders 9 
            Modern medicine offers limited success in providing effective cure and there is a need 
to develop new drugs capable of healing toxic liver damages. The available synthetic drugs to 
treat liver disorders also cause further damage to the liver.  The use of the herbal medicines in 
hepatic disorders has been known in Indian since the Vedic times. About 170 phyto-
constituents isolated from 110 plants belonging to 55 families have been reported so far to 
possess liver protective activities. It is estimated that about 6000 commercial herbal drugs are 
used world over as hepatoprotective drugs.  
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              However, the following four herbal medicines have been found to be most promising 
in the treatment of liver disorders and viral hepatitis. 
 Silymarin obtained from the seeds of Silibum marianum 
 Extracts of Picrrorhiza kurroa known as kutaki 
 Extracts of Phyllanthus niruri and Phyllanthus amarus 
 Glycyrrhizin  from Glycyrrhiza glabra 
             The genus Vitex contains 270 species distributed throughout the world. It has a 
proven potential of important pharmacological interest.  
The species Vitex agnus-castus (Verbenaceae) generally called as the women’s herb, 
has a folklore claim of treating liver disorders. Hence the present study was carried out to 
evaluate the potential effect of Vitex agnus-castus in treating liver disorders.  
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2. RATIONALE FOR SELECTION OF THE PLANT 
 Herbalism has a long term tradition of use outside of conventional medicine. It is 
becoming more main stream as improvements in analysis and quality control along 
with advances in clinical research have enhanced the value of herbal medicine in 
treating and preventing diseases. There are numerous plants and traditional 
formulations available for the treatment of liver diseases. 
 There are no specific synthetic drugs used as hepatoprotective. Many herbs contain 
biomolecules which are biodegradable and can be broken down into basic elements. 
Hence herbal drugs are preferred more for treating liver damage over synthetic drugs. 
 There is a long tradition for the use of different preparations of drugs of Vitex agnus 
castus (VAC) belonging to the family Verbenaceae as complementary medicine in 
Europe.  
 VAC is also reported to possess antioxidant activity and antioxidants are known to 
possess hepatoprotective activity. Plants containing flavonoids are known to enhance 
the hepatoprotective activity. 
 This plant has been traditionally used for treating enlarged liver and no scientific 
studies have been reported so far. Hence the present work is intended to be carried out 
to evaluate the hepatoprotective activity on the berries of Vitex agnus-castus. 
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                     3. REVIEW OF LITERATURE 
The literature review of the plant Vitex agnus-castus reveals the following: 
 E. Svecova et al (2013) reported the antifungal activity of the methanolic seed extract 
of Vitex agnus-castus against Pythium ultimum in tomato.  The 0.2% extract delayed 
the mycelial growth of the fungus and showed significant antifungal activity against 
P. ultimum on tomato seedlings with an efficacy comparable to that of the synthetic 
fungicide.19 
  Ghannadi A et al (2012) reported the antibacterial activity and composition of 
essential oils from aerial parts of Pelargonium graveolens L’Her and seeds extract of 
Vitex agnus-castus L. Inhibition zones showed that the essential oils of the two plants 
were active against bacteria. The susceptibility of the strains changed with the dilution 
of essential oils in DMSO.20 
  M. Ramezani et al (2010) reported the antinociceptive and anti-inflammatory effects 
of hydroalcoholic extract of Vitex agnus castus Fruit. The inflammation was caused 
by xylene induced ear oedema. The results indicated the Vitex extracts remarkably 
inhibited inflammation and second phase of nociception.21 
 Anita Rani Shiksharthi et al (2012) reported the anti-anxiety and CNS modulatory 
activities of Vitex agnus-castus fruits Linn. The methanolic and water extract 
exhibited significant anti-anxiety activity at the dose of 200mg/kg with respect to the 
control as well as standard (diazepam 2mg/kg). 22 
 Jenive Stella et al (2011) reported the hypoglycemic effect on the methanolic extract 
of leaves of Vitex Agnus Castus in Streptozotocin induced diabetic rats. 
Streptozotocin (40mg/kg body weight) was used to induce diabetes mellitus. 
Treatment with Vitex agnus-castus extract at three doses (50, 100, 200mg/kg bw) 
showed a significant increase in serum insulin and significant decrease in blood 
glucose levels.23 
 Shao-Nong Chen et al (2011) reported the phytochemical investigation of Vitex 
agnus-castus fruits.24 
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 He Zhong et al (2009) have carried out a prospective, randomnized multicentre 
placebo controlled study in China to study the effect of Vitex agnus-castus for the 
treatment of premenstrual syndrome. The study concluded that the dry extracts of 
Vitex agnus-castus fruits is an effective and well tolerated treatment for the relief of 
symptoms of premenstrual syndrome.25  
 Ayse et al (2008) reported the antioxidant potency of flavonoids from methanolic 
extract of flowering stems of Vitex agnus-castus L. The antioxidant activity of 
compounds on DPPH were found to be very high.26 
 Saberi  Mehdi et al (2008) reported the antiepileptic activity of Vitex agnus castus 
fruit extract on amygdalin kindled seizures in male rats. The results indicate that Vitex 
can reduce or prevent epileptic activity as demonstrated by reduction of ADD(after 
discharge duration) and S5D (length of convulsion) in a dose dependent manner.27 
 Males et al (1998) have studied and reported the content of the polyphenols in leaves, 
flowers and fruits of Vitex agnus-castus L.28 
Hepatoprotective activity: 
 Amol Nimba More et al (2013) Evaluation of activity of whole stem extracts of 
Oroxylum indicum against paracetamol induced hepatotoxicity. This study indicated 
that aqueous and ethanolic extracts showed significant hepatoprotective activity by 
preventing hepatic damage at the dose of 250mg/kg.29 
 Sabeena Hussain Syed et al (2013) reported the hepatoprotective activity on the 
methanolic extract of the leaves of Erythroxylum monogynum Roxb. by paracetamol 
induced toxicity. It showed a dose dependent activity which is evident from the 
decreased level of serum enzymes and total bilirubin at dose of 400mg/kg compared 
to 100mg/kg and 200mg/kg.30 
 Manoj Sony et al (2011) reported the Hepatoprotective activity of fruits of Prunnus 
domestica against paracetamol and CCl4 induced hepatotoxicity. Extract of Prunnus 
domestica fruits (150mg/kg and 300mg/kg) has brought back the altered levels of 
biochemical markers to the near normal levels in a dose dependant manner.31 
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 Jagdish R. Bahetl et al (2011) reported that the methanolic extract of Ficus 
bengalensis barks exhibited antihepatotoxic effect against paracetamol and CCl4 
induced hepatic damage at the dose level of 100mg/kg and 250mg/kg.32 
 Mohammed Ibrahim et al (2011) reported the hepatoprotective activity of barks 
Boswellia serrata against paracetamol induced hepatotoxicity. The chloroform bark 
extract was found to be hepatoprotective at the dose of 250mg.kg and 500mg/kg.33 
 Satyaranjan Mishra et al (2013) Evaluation of the anti-hepatotoxic activity of 
methanol-dichloromethane (MDM) extract of whole plant of Oroxylum indicum on 
carbon tetrachloride induced hepatotoxicity. The MDM extract of Oroxylum indicum 
whole plant (200mg/kg) exhibited a significant reduction in biochemical parameters 
thus reversing hepatotoxicity causing significant liver recovery. 34 
 M. Balakrishnan et al (2012) reported the Hepatoprotective activity on the root bark 
of Azima tetracantha Lam. against carbon tetrachloride induced hepatotoxicity. The 
regeneration of damaged liver cells was obtained by the ethanolic extract of the plant 
at the doses 40, 80, 120mg/kg. 35 
 Manjunatha BK et al (2012) reported the Hepatoprotective potency on the ethanolic 
seed extracts of Achyranthus aspera which exhibited recovery against the toxic 
effects of CCl4 at the dose of 100mg/kg.36 
 Veena Rani I et al (2011) reported the hepatoprotective activity different extracts of 
Bauhinia purpurea against CCl4 induced toxicity. The maximum protection was seen 
with alcoholic and chloroform extracts at the dose of 150mg/kg.37 
 Rakhamaji D. Chandane et al (2013) reported the hepatoprotective activity of honey 
on anti-tubercular drugs (isoniazid, rifampicin, pyrazinamide) induced hepatotoxicity.  
Honey inhibits lipid peroxidation and by increasing antioxidant defence mechanism 
has a significant hepatoprotective action. 38 
 
      From the above models it is known that hepatotoxicity may be caused by various 
methods. Drug related hepatotoxicity is the one which is life threatening and /or requires 
hospitalisation in serious cases. Among the drugs, paracetamol was found to be one of the 
common analgesic antipyretic used by the population and found to cause hepatotoxicity and 
liver damage at high doses. Hence paracetamol induced toxicity model was selected for this 
study. 
                                                                         Ethnobotanical survey 
 
Department of Pharmacognosy, COP, MMC. Page 9 
 
4. ETHNOBOTANICAL SURVEY 
PLANT PROFILE 10,11  
Plant name  :  Vitex agnus-castus 
Family         : Verbanaceae 
VERNACULAR NAMES 
Tamil           :    Vennochi 
English        :    Hemp tree, Monk’s pepper 
PLANT TAXONOMY 
Kingdom     :    Plantae 
Division      :    Tracheophyta  
Class           :    Magnoliopsida 
Order          :    Lamiales 
Family        :    Verbanaceae 
Genus         :    Vitex 
Species       :    agnus-castus 
 
DESCRIPTION: 12 
Habit: Deciduous tree or large shrub, growing to a height of 7 metres. 
Habitat: Native to western Asia and Mediterranean region. 
 
BOTANY12 
Leaves: Opposite, decussate, rarely whorled or alternate, exstipulate, simple, rarely 
compound. 
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Flowers: zygomorphic, bisexual and hypogynus. 
Fruits: schizocarpic or drupaceous with hard endocarp, indehiscent or dehiscent. 
Parts used: berries, leaves, roots 
 
                              
Fig. 1. Vitex agnus-castus tree 
 
CHEMICAL CONSTITUENTS: 13,14 
 Flavonoids               - vitexin, casticin, kampferol, quercetagetin 
 Iridoid glycosides    - agnoside, aucubin 
 Alkaloids                 - viticin 
 Volatile oil               - 1,8-cineol, linalool, terpinyl acetate, alpha pinene, beta pinene 
 Progestins                 - progesterone, hydroxyl progesterone 
 Essential fatty acids - palmitic acid, oleic acid, linoleic acid 
 
ETHNOBOTANICAL USES:  

 Decoction of berries – Used as stimulant, diuretic and in the treatment of dropsy, liver 
disorders, premenstrual syndrome and cancer.10,11 

 Leaves – Used in premenstrual syndrome, mastalgia, hormonal disorders, menstrual 
cramps, liver disorders. 15 
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
 It has other uses such as: 16,17,18 
 Antioxidant  
 Antimicrobial  
 Anti-Inflammatory 
 Spasmolytic  
 Antiviral 
 Antithyroid 
 Anti-tumor 
 Anti-acne 
 Cytotoxic  
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5. AIM AND OBJECTIVE 
 
The aim of the present study is 
 To standardize the berries of Vitex agnus-castus by carrying out the 
pharmacognostical, physicochemical and phytochemical parameters. 
 
 To evaluate the antioxidant activity of the various extracts of the berries of Vitex 
agnus-castus. 
 
 To evaluate the in vitro Hepatoprotective activity of the various extracts of the berries 
of Vitex agnus-castus by MTT assay using normal Chang liver cell line  
 
 Evaluation of in vivo Hepatoprotective activity of the berries of Vitex agnus-castus by 
using Paracetamol induced toxicity in Wistar albino rats. 
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6. PLAN OF WORK 
1. PHARMACOGNOSICAL STUDIES 
 Collection of plant material 
 Authentication  
 Macroscopical studies 
 Microscopical studies 
 Powder microscopy 
 Physicochemical constants 
o Ash values  
o Extractive values  
o Loss on drying 
o Foaming index  
o Swelling index 
 Inorganic and Heavy Metal Analysis 
 
 
2. PHYTOCHEMICAL STUDIES 
 Preparation of extracts 
 Preliminary phytochemical screening of powder and extracts 
 Quantitative estimation of Phytoconstituents 
 Fluorescence analysis of powder and extracts 
 Thin layer chromatography of extracts 
 HPTLC 
 
3. PHARMACOLOGICAL SCREENING 
 Antioxidant activity 
o Hydrogen peroxide scavenging assay 
o Reducing power ability assay 
 In vitro evaluation by MTT assay using Chang liver cell line 
 In vivo hepatoprotective activity using paracetamol induced hepatotoxicity 
model. 
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7. METHODOLOGY 
7.1. PHARMACOGNOSTICAL STUDIES 
         Evaluation of a drug means confirmation of its identity and to determine its quality and 
purity and detection of nature of adulteration. Evaluation of a crude drug can be attempted by 
different methods which include morphological and microscopical studies of the crude drugs 
or their physical, chemical and biological behaviour. Systematic identification of crude drugs 
and their quality assurance gives an integral part of drug description. 
         Pharmacognostical studies basically deals with the identification, authentication and 
standardization of herbal medicinal plants through organoleptic character, histological 
character, powder microscopy, quantitative microscopy, linear measurement, histochemical 
analysis and physico-chemical observations as prescribed by an authoritative source such as 
World Health Organization (WHO). 
7.1.1. PLANT COLLECTION AND AUTHENTICATION 
        The fresh berries of the plant Vitex agnus-castus was collected from Rajavallipuram, 
Thirunelveli district, Tamil Nadu, India and it was botanically identified and authenticated by 
Dr. V. Chelladurai, Research Officer- Botany (Scientist – C), Central Council for Research in 
Ayurveda and Siddha, Government of India. 
7.1.2 MACROSCOPY 39 
        Macroscopical character which includes organoleptic characters and morphological 
features of various parts of the plant was studied. 
7.1.3. MICROSCOPY 
Staining Method  
         Fixation of plant organ: Berries were cut fixed in FAA solution (Formalin 5ml + 
Acetic acid + 90ml of 70% Ethanol). After 24 hours of fixing, the specimens were dehydrated 
with graded series of tertiary butyl alcohol, as per standard method.40 
         Infiltration of the specimen: It was carried out by gradual addition of 58 - 60˚C of 
melting pointed paraffin wax until TBA solution attained super saturation. The specimens 
were cast into paraffin blocks.41 
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Sectioning 42 
          The paraffin embedded specimens were sectioned with the help of rotary microtome. 
The thickness of the sections was 10 – 12µg. Dewaxing of the sections was done by 
customary procedures. The sections were stained with saffranin, haematoxylin and eosin.  
          The dye rendered blue colour to the cellulose walls, pink colour to the lignified cells, 
dark green to suberin, violet to the mucilage, blue to the protein bodies etc. wherever 
necessary sections were also stained with saffranin, fast green and iodine for starch. 
Photomicrographs   
         Microscopic description of tissues was supplemented with micrographs wherever 
necessary. Photographs of different magnifications were taken with Nikon lab photo 2 
microscopic units. For normal observations bright fields was used. 
         For the study of crystals and lignified cells, polarized light was employed. Since, these 
structures have birefringent property under polarized light they appear bright against dark 
background. Magnifications of the figures are indicated by the scale – bars. Descriptive terms 
of the anatomical features are as given in the standard anatomy books.  
7.1.4. POWDER MICROSCOPY 43 
        The shade dried, powdered plant material was used for powder microscopic analysis. 
The organoleptic characters were observed and to identify the different characteristic 
features, various staining reagents were used. Powder was stained with 1% Phloroglucinol in 
90% ethanol, concentrated hydrochloric acid and glycerin and observed through microscope. 
All the lignified cells stained pink colour. Calcium oxalate crystals were observed under the 
polarized light microscope. 
   
 
  
 
 
                                                                                                Methodology 
 
Department of Pharmacognosy, COP, MMC. Page 16 
 
7. 1.5.  PHYSICOCHEMICAL CONSTANTS 44-47 
 Shade dried powdered plant material of berries of Vitex agnus-castus, was used for 
the determination of physicochemical constants in accordance with WHO (World Health 
Organization) guidelines. 
7.1.5.1. Determination of ash values 
        Ash values are helpful in determining the quality and purity of a crude drug in the 
powdered form. The residue remaining after incineration is the ash content of the drug, which 
simply represents inorganic salts, naturally occurring in drug or adhering to it or deliberately 
added to it, as a form of adulteration. 
 Total ash 
           Total ash is designed to measure the total amount of material remaining after ignition. 
This includes both physiological ash which is derived from plant tissue itself and non-
physiological ash which is the residue of the extraneous matter adhering to the plant surface. 
Procedure  
           Silica crucible was heated to red hot for 30 minutes and it was allowed to cool in a 
dessicator. About 2-3g of powdered sample was weighed accurately and evenly distributed in 
the crucible dried at 100 - 105˚C for 1 hour and ignited to constant weight in a muffle furnace 
at 600±25˚C. The crucible was allowed to cool in dessicator and ignited to constant weight. 
The percentage of ash with reference to the air dried substance was then calculated. 
 Water soluble ash 
          The total ash was boiled for 5 minutes with 25ml of water. The insoluble matter was 
then collected in ash less filter paper. It was washed with hot water and ignited for 15 minutes 
at a temperature not exceeding 450˚C. The weight of the insoluble matter was subtracted 
from the weight of ash and then the percentage of water soluble ash with reference to the air 
dried substance was calculated.  
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 Acid insoluble ash 
         In a crucible containing total ash, 15ml of water and 10ml of hydrochloric acid were 
added. It was boiled for 10 minutes and filtered on an ashless filter paper. The filter paper 
was washed with hot water until the filtrate was neutral. The filter paper with the contents 
was ignited to dull redness, cooled in a dessicator and weighed. The percentage of acid 
insoluble ash was calculated with reference to the air dried substance. 
 Sulphated ash  
         2-3g of air dried substance was ignited gently at first in a crucible, until the substance 
was thoroughly charred. Then the residue was cooled, moistened with 1ml of sulphuric acid, 
heated gently until the white fumes were no longer evolved and ignited at 800±25˚C, until all 
the black particles disappeared. The crucible was allowed to cool, a few drops of sulphuric 
acid was added and heated. Then it was ignited as before, cooled and weighed. The 
percentage sulphated ash with reference to the air-dried substance was then calculated.  
7.1.5.2. Determination of solvent extractive values 
           This method determines the amount of active constituents in a given amount of 
medicinal plant material when extracted with a particular solvent. The extraction of any crude 
drug with a particular solvent yields a solution containing different Phytoconstituents. The 
composition of these Phytoconstituents in that particular solvent depends upon the nature of 
the drug and solvent used. The use of a single solvent can be the means of providing 
preliminary information on the quality of a particular drug. 
 Water soluble extractive value 
Procedure  
           5g of the air-dried drug, coarsely powdered was macerated with 100ml of water in a 
closed flask for 24 hours, shaking frequently during first 6 hours and allowed to stand for 18 
hours. Thereafter, filter rapidly taking precautions against loss of water, evaporate 25ml of 
the filtrate to dryness in a tared, flat-bottomed shallow dish, dry at 105˚C and weigh. The 
percentage of water-soluble extractive with reference to the air dried drug was calculated. 
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 Alcohol soluble extractive value 
          The alcohol soluble extractive value is also indicative for the same purpose as water 
soluble extractive value. The solvent strength of alcohol varies from 20 – 95 % v/v
.
 The 
solvent strength has to be chosen depending on the nature of drugs to be extracted. 
Procedure  
         5g of the air dried and coarsely powdered drug was macerated with 100ml of ethanol 
of 50ml in a closed flask for 24 hours, shaking frequently during the first 6 hours and allowed 
to stand for 18 hours. Thereafter, the solution was filtered rapidly taking precaution against 
loss of ethanol. Evaporate 25ml of the filtrate to dryness in a tared flat-bottomed shallow 
dish, dry at 105˚C and weigh. The percentage of ethanol-soluble extractive with reference to 
the air-dried drug was calculated. 
 Non-volatile ether soluble extractive value (Fixed oil content) 
  A suitably weighed quantity of the crushed air dried drug was transferred to an 
extraction thimble and extracted with solvent ether or petroleum ether (boiling point 40-60˚C) 
in a soxhlet for 6 hours. The extract was filtered into a tarred evaporating dish, evaporated 
and dried at 105˚C to constant weight. The percentage of non-volatile ether soluble extractive 
value with reference to the air dried drug was calculated. 
 Volatile ether soluble extractive value 
         About 2g of dried powdered drug was accurately weighed and extracted with 
anhydrous ethyl ether in a continuous extractive apparatus for 20 hours. The ether solution 
was transferred to a tared porcelain dish and evaporated spontaneously. Then it was dried 
over phosphorous pentoxide for 18 hours and the total ether extract was weighed. The extract 
was heated gradually and dried at 105˚C to constant weight. The loss in weight represents the 
volatile portion of the extract. 
7.1.5.3. Loss on drying 
         Specified quantity of substance was transferred to a previously ignited and cooled 
silica crucible and the substance was evenly distributed by gentle sidewise shaking. The 
crucible with the contents and the lid were weighed accurately. Then the loaded uncovered 
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crucible and the lid were placed in a drying chamber (105˚C). The substance was heated for 
sufficient period of time until constant weight was obtained. The crucible was covered with 
the lid and allowed to cool in a dessicator at room temperature before weighing. Finally the 
crucible was weighed to calculate the loss on drying with reference to the air dried substance. 
7.1.5.4. Determination of foaming index 
         1g of the coarsely powdered drug was weighed and transferred to 500ml conical flask 
containing 100ml boiling water. The flask was maintained at moderate boiling point at 80-
90˚C for about 30 minutes. Then it was cooled and filtered into a volumetric flask and 
sufficient water was added through the filter to make up the volume to 100ml (V1).  
        The decoction was poured into 10 stoppered test tubes (height 16cm, diameter 
16mm) in successive portions of 1ml, 2ml, 3ml, etc., upto 10ml, and the volume was adjusted 
in each tube to 10ml water. Stopper the tubes and shake them in a lengthwise motion for 15 
seconds, two shakes per second. Allow to stand for 15 minutes and measure the height of the 
foam. The results are accessed as follows. 
             If the height of the foam in every tube is less than 1cm, the foaming index is less than 
100. If a height of 1cm is measured in any tube, the volume of the plant material decoction in 
the tube (a) is used to determine the index. If this tube is the first or second tube in a series, 
prepare an intermediate dilution in a similar manner to obtain a more precise result.  
           If the height of the foam is more than 1cm in every tube, the foaming index is over 
1000. In this case repeat the determination using a new series of dilutions of the decoction in 
order to obtain a result. 
Calculate the foaming index using the following formula, 
                        Foaming index = 1000/a 
where  a = the volume in ml of the decoction 
7.1.5.5. Determination of swelling index   
        The swelling index is the volume in ml occupied by the swelling of 1g of plant 
material under specified conditions. A specified quantity of the plant material previously 
reduced to the required fineness and accurately weighed, into a 25ml glass stopper measuring 
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cylinder. The internal diameter of the cylinder should be about 16mm, the length of the 
graduated portion about 125mm, marked in 0.2ml divisions from 0 to 25ml of water and 
shake the mixture thoroughly every 10 minutes for 1 hour. Allow to stand for 3 hours at room 
temperature, or as specified.  The volume in ml occupied by the plant material was measured 
including any sticky mucilage.  The mean value of the individual determination, related to 1g 
of plant material was calculated. 
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7.1.6. QUALITATIVE AND QUANTITATIVE ESTIMATION OF HEAVY METALS 
AND INORGANIC ELEMENTS 48 
            Plant minerals play a vital role in metabolism and osmolity. Presence of elements vary 
with the soil, climate conditions etc. There are essential and non-essential elements which 
may be beneficial or harmful to living things. Non-essential elements like lead, arsenic, 
cyanide, chromium, cadmium, aluminium and silver bring about toxic effects resulting in 
intoxication. Hence, qualitative and quantitative estimation of inorganic elements in the plant 
Vitex agnus-castus were carried out. 
7.1.6.1. Qualitative analysis of inorganic elements and Heavy metals 
           To the ash of the drug material 50% v/v HCl was added and kept for 1 hour. It was 
filtered and the filtrate was used for the following tests. 
Aluminium: White gelatinous precipitate of aluminium hydroxide [Al(OH)3] is formed on 
addition of ammonia solution. It is slightly soluble in excess of the reagent. It dissolves 
readily in strong acid and base. 
Arsenic: Arsenious salts in neutral solution react with solution of copper sulphate to form 
green precipitate (Scheele’s green) which on boiling gives a red precipitate of cupric oxide. 
Borate: The mixture obtained by the addition of sulphuric acid and alcohol (95%) to a 
borate, when ignited burns with flame tinged with green.   
Calcium: Solution of calcium salts, when treated with ammonium carbonate solution yields a 
white precipitate. The mixture after boiling and cooling is insoluble in ammonium chloride 
solution.  
Carbonate: Carbonate, when treated with dilute acid produces effervescence liberating CO2 
which is colourless and produces a white precipitate in calcium hydroxide solution. 
Chlorides: Chlorides, when treated with silver nitrate solution yield a curdy white precipitate 
which is insoluble in nitric acid, but soluble after being well washed with water. 
Copper: An excess of ammonia solution added to a solution of a cupric salt, produces first a 
bluish precipitate and then a deep blue coloured solution.  
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Iron: Solution of ferric salts, when treated with potassium ferrocyanide solution, yields an 
intense blue precipitate which is insoluble in dilute HCl.  
Lead: Strong solution of lead salts, when treated with HCl, yield a white precipitate which is 
soluble in boiling water and is re-deposited as crystals when the solution is cooled. 
Magnesium: Solution of magnesium salts, when boiled with ammonium carbonate solution 
yields white precipitate, but no precipitate is produced with ammonium chloride solution.  
Mercury: Solution of mercuric salts, when treated with sodium hydroxide solution, yields a 
yellow precipitate. 
Nitrate: With solution of ferrous sulphate no brown colour was observed but if sulphuric 
acid is added (slowly along the sides of the test tube), a brown colour is produced at the 
junction of two liquids, indicating the presence of nitrates. 
Phosphate: Solution of phosphate when treated with silver nitrate solution yield yellow 
precipitate of normal silver orthophosphate Ag3PO4 (distinction from meta and 
pyrophosphate) solution in dilute ammonia solution and in dilute nitric acid. 
Potassium: Moderately strong solution of potassium salts, which have been previously 
ignited to remove ammonium salts, when treated with perchloric acid (60%) yield a white 
crystalline precipitate. 
Silver: Solution of silver salts, when treated with potassium iodide solution yield a cream 
coloured precipitate which is insoluble in dilute ammonia solution and nitric acid. 
Sulphate: Solution of sulphate, when treated with lead acetate solution yields a white 
precipitate which is insoluble in ammonium acetate solution and sodium hydroxide solution.  
7.1.6.2. Quantitative estimation of inorganic elements: 
Instrumental parameters:  
            Instrument Name  : Inductively Coupled Plasma Optical Emission Spectrometry 
            Instrument Model : PE Optima 5300 DV ICP-OES 
            Optical system Dual View – axial or radial 
                                                                                                Methodology 
 
Department of Pharmacognosy, COP, MMC. Page 23 
 
            Detector system     : Charge coupled detector, (UV-VISIBLE detector which is 
maintaining at - 40˚C ) to detect the intensity of the emission line wavelength range from 165 
to 782nm. 
              Torch (Light source) : Positioned horizontally in the sample compartment along the 
central axis of the spectrometer optics. Changing from axial to radial viewing in a simple 
software command and is accomplished by computer control of a mirror located in the optical 
path. The torch assembly of this system comprises of two concentric quartz tubes.      
             Spray chamber           :  Scott type 
             Nebulizer                     :  Cross flow Gem tip 
Preparation of samples by acid digestion method 
             Weighed 50g of powdered mixture of powered drug treated with acid mixture of 
Sulphuric acid: Water in the ratio of 4 : 1 in the kjeldhal flask and heated continuously till the 
solution is colourless. The sample mixture was then transferred in a 25ml volumetric flask 
and made upto the volume with distilled water. 
              Blank solution was prepared as above without sample. 
              The standards of arsenic, lead, cadmium, manganese, boron, calcium, mercury were 
prepared as per the protocol and the calibration curve was developed for each of them.  
Detection  
           Samples were analysed for the detection and Quantification of arsenic, lead, cadmium, 
manganese, boron, calcium, mercury by Inductive Coupled Plasma Optical Emission 
Spectrometry. 
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7.2. PHYTOCHEMICAL STUDIES 
               Phytochemical evaluation is used to determine the nature of phytoconstituents 
present in the plant by using suitable chemical tests. It can be done by qualitative analysis 
using specific reagents followed by confirmation with different chromatographic techniques 
like TLC and HPTLC. Therefore a complete investigation is required to characterize the 
phytoconstituents qualitatively and quantitatively. 
 MATERIALS AND METHODS 
7.2.1. PREPARATION OF EXTRACTS 49 
              Extraction is the preliminary step involved in the phytochemical studies. It brings 
out the primary and secondary metabolites into the extracting solvent depending on its 
polarity. 
Continuous hot percolation method 
             The dried coarsely powdered berries of Vitex agnus-castus were extracted, using 
soxhlet apparatus, with solvents of increasing polarity such as Hexane, Ethyl acetate and 
Ethanol at 60-70˚C for of 18 hours. All the extracts were redistilled and concentrated under 
rotary vacuum evaporator and percentage yield was calculated. The extracts were tested for 
qualitative and quantitative analysis. 
7.2.2. PRELIMINARY PHTOCHEMICAL SCREENING 50,51 
7.2.2.1. QUALITATIVE ANALYSIS 
1. Detection of Carbohydrates 
 Molisch test  
                 The extracts and powder were treated with a few drops of alcoholic α-naphthol,     
then add few drops of concentrated sulphuric acid through the sides of the test tube. 
Formation of purple to violet colour ring appears at the junction of the test tubes indicating 
the presence of Carbohydrates. 
 Fehling’s test 
                 The extracts and the powder were treated with Fehling’s A and Fehling’s B 
solution and heated. Formation of red colouration indicates the presence of sugar. 
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2. Detection of Alkaloids 
 Dragendorff’s reagent 
               The extracts and the powder were treated with a few drops of Dragendorff’s 
reagent. Formation of an orange or orange red precipitate indicates the presence of Alkaloids. 
 Mayer’s reagent 
              The extracts and the powder were treated with a few drops of Mayer’s reagent. 
Formation of creamy white precipitate indicates the presence of Alkaloids. 
 Wagner’s reagent 
              The extracts and the powder were treated with a few drops of Wagner’s reagent. 
Formation of brown or reddish brown precipitate indicates the presence of alkaloids. 
3. Detection of Flavonoids 
 Shinoda test 
              The extracts and the powder were treated with a few magnesium turnings and 
concentrated hydrochloric acid added drop wise. Formation of pink, scarlet, crimson red or 
occasionally green to blue colour which appear after a few minutes, indicates the presence of 
flavonoids. 
 Alkaline reagent test 
              The extracts and the powder were treated with a few drops of sodium hydroxide 
solution; formation of intense yellow colour indicates the presence of flavonoids. 
4. Detection of Glycosides 
 Borntrager’s test 
             The extracts and the powder were boiled with 1ml of sulphuric acid for 5 minutes and 
filtered while hot. The filtrate was cooled and shaken with equal volume of chloroform. The 
lower layer of chloroform was separated and shaken with half of its volume of dilute 
ammonia. Formation of rose pink to red colour in the ammoniacal layer indicates the 
presence of glycosides. 
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 Test for hydroxy-anthraquinones  
              The extracts and the powder were treated with a few drops of potassium hydroxide 
solution. Formation of red colour indicates the presence of glycosides. 
5. Detection of Saponin 
 Froth formation test 
               The extracts and the powder were shaken well with water. Formation of stable froth 
indicates the presence of glycosides. 
6. Detection of Tannins (Phenolic compounds) 
 Ferric chloride test 
               The extracts and the powder were treated with a few drops of ferric chloride 
solution. Formation of green colour indicates the presence of tannins.  
 Gelatin test 
              The extracts and the powder were treated with a few drops of 1% gelatin solution 
containing 10% sodium chloride. Formation of precipitate indicates the presence of tannins. 
7. Detection of Phytosterols 
 Libermann-Burchard test 
               The extracts and the powder were treated with a few drops of acetic anhydride, 
boiled and cooled. Then concentrated sulphuric acid was added along the sides of the test 
tube. A brown ring formation at the junction of two layers and upper layer turning green 
shows the presence of steroids and formation of deep red colour indicates the presence of 
triterpenoids. 
8. Detection of Proteins and Amino acids 
 Biuret test 
             The extract and the powder were treated with a few drops of Biuret reagent. 
Formation of violet colour indicates the presence of proteins. 
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 Xanthoprotein test  
             The extracts and the powder were treated with a few drops of conc. Nitric acid and 
boiled, yellow precipitate is formed. After cooling it, add 40% sodium hydroxide solution. 
Formation of orange colour indicates the presence of proteins. 
 Ninhydrin test 
            The extracts and the powder were treated with a few drops of 0.25 % ninhydrin 
reagent and boiled for few minutes. Formation of blue colour indicates the presence of 
proteins. 
9. Gums and mucilage 
             The extracts and the powder were treated with ruthenium red solution. Formation of 
pink colour indicates the presence of gums and mucilage. 
             The extracts and the powder were dissolved in 5 to 10 ml of acetic anhydride by 
means of gentle heat, cooled and 0.05ml of conc. Sulphuric acid was added. Formation of a 
bright purplish red colour indicates the presence of gums and mucilage. 
10. Detection of Fixed oils and fats 
 Stain test 
             Small quantities of extracts were pressed between two filter papers. An oily stain on 
filter paper indicates the presence of fixed oils and fats. 
11. Detection of resins 
 Acetone-water test 
             Extracts were treated with acetone. Small amount of water was added and shaken. 
Appearance of turbidity indicates the presence of resins. 
7.2.2.2. QUANTITATIVE ESTIMATION OF PHYTOCONSTITUENTS  
 Total flavonoid content 52 
            Aluminium chloride colorimetric method was used for Flavonoids determination. The 
plant extracts (0.5ml of 1:10 mg/ml in methanol) were separately mixed with 1.5ml of 
methanol, 0.1 ml of 10% aluminium chloride, 0.1ml of 1M sodium acetate and 2.8ml of 
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distilled water. It was kept at room temperature for 30 minutes and absorbance of the reaction 
mixture was measured at 415nm with double beam UV spectrophotometer. The calibration 
curve was prepared by preparing Quercetin solutions at concentrations 10, 20, 30, 50 to 
100µg/ml in methanol. 
 Total phenol content 53 
           Standard Gallic acid (10mg) was dissolved in 100ml distilled water in a volumetric 
flask (100µg/ml of stock solution). From the above stock solution, 0.5 to 2.5ml of aliquots 
was pipetted out into 25ml volumetric flasks. Then 10ml of distilled water and 1.5ml of 
Folin-Ciocalteu reagent, diluted according to the label specification were added to each of the 
above volumetric flasks. After 5 minutes, 4ml of 1M sodium carbonate was added and 
volume was made upto 25ml with distilled water. At the same time, the plant extracts (0.5ml 
of 1:10mg/ml) in methanol were separately mixed with above reagents. After 30 minutes, 
absorbance at 765nm was recorded and calibration curve for standard was plotted as 
absorbance Vs concentration. From this graph the amount of phenolic content was 
determined.  
 
7.2.3. FLUORESCENCE ANALYSIS 54,55 
             Fluorescence analysis was carried out according to the method of Chase and Pratt 
(1949) and Kokoshi et al. (1958) in day light and in UV light. The plant powders and extracts 
were treated with different solvents and the fluorescence was observed in day light and in 
near far UV light and results were tabulated.  
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7.2.4. CHROMATOGRAPHY 56,57 
             Chromatographic technique is an important analytical tool in the separation, 
identification and estimation of different phytoconstituent presents in the plant extract. 
7.2.4.1. THIN LAYER CHROMATOGRAPHY 
Principle  
             Thin layer chromatography is a technique used for the separation, identification and 
estimation of single or mixture of components present in the various extracts. It is a reliable 
technique in which solute undergoes distribution between two phases, stationary phase and 
mobile phase. The separation is mainly based on the differential migration that occurs when a 
solvent flows along the thin layer of stationary phase. This may be achieved by partition and 
adsorption depending on stationary phase used.  
TLC Plate preparation 
            The plates were prepared using TLC spreader. 40g of silica G was mixed with 85ml 
of water to prepare homogenous suspension and poured in a spreader. 0.25mm thickness of 
plates was prepared, air dried until transparency of the layer disappeared, then dried at 110˚C 
for 30 minutes and kept in a dessicator.  
Selection of mobile phase 
             The solvent mixture was selected on the basis of the phytoconstituents present in 
each extract. Factors such as nature of components, stationary phase, mobile phase, polarity, 
influence the rate of separation of constituents. 
Solvent system:  
The extracts were run in following mobile phases:                                      
Ethyl acetate: formic acid: glacial acetic acid: water :: 100:11:11:26 
Hexane: ethyl acetate :: 6:4  
Toluene: ethyl acetate: diethylamine :: 70:20:10 
Detection was done under UV at 254nm and 365nm 
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7.2.4.2. HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY-FINGER 
PRINT PROFILE 58 
              HPTLC is one of the versatile chromatographic method which helps in identification 
of compounds and thereby authentication of purity of herbal drugs. The time required in this 
method for the demonstration of most of the characteristic constituents of a drug is very quick 
and short. In addition to qualitative detection, HPTLC also provides semi-quantitative 
information on major active constituents of a drug, thus enabling an assessment of drug 
quality.  
              HPTLC serves as a convenient tool for finding the distribution pattern of 
phytoconstituents which is unique to each plant. The fingerprint obtained is suitable for 
monitoring the identity and purity of drugs and for detecting adulteration and substitution. 
HPTLC technique is helpful in order to check the identity, purity and standardize the quantity 
of active principles present in the herbal extract. 
Instrument conditions  
Sample used                         : Ethyl acetate extract 
Instrument                           : CAMAG HPTLC  
HPTLC Applicator              : CAMAG LINOMAT IV 
HPTLC Scanner                  : CAMAG TLC SCANNER II 
Sample dilution                    : 10mg of sample dissolved in 1ml of ethyl acetate  
Volume of injection              : 20µl 
Mobile phase                        : ethyl acetate: hexane:: 6:4 
Lamp                                    : deuterium 254nm 
Stationary phase                  : TLC silicagel 60F254, Merck 
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Chromatographic condition  
              The estimation has been done using the following chromatographic conditions. 
Chromatography was performed on a 10×10 cm pre activated HPTLC silica gel 60 F254 
plate. Samples were applied to the plate as 6mm wide band with an automatic TLC applicator 
Linomat IV with Nitrogen flow (CAMAG, Switzerland), 8mm from the bottom. 
Densitometric scanning was performed on CAMAG  scanner II. The plates were pre washed.  
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7.3. PHARMACOLOGICAL STUDIES 
7.3.1. ANTIOXIDANT ACTIVITY 
7.3.1.1. Hydrogen peroxide scavenging method  
           The ability of the Vitex agnus-castus to scavenge hydrogen peroxide was determined 
according to the method of Ruch.59 A solution of hydrogen peroxide (2mmol/l) was prepared 
in phosphate buffer (pH 7.4). Vitex agnus-castus (10-100µg/ml) were added to hydrogen 
peroxide solution (0.6ml). Absorbance of hydrogen peroxide at 230nm was determined after 
10 minutes against a blank solution containing phosphate buffer without hydrogen peroxide. 
% scavenging activity [H2O2] = A (control) – A (standard) ×100  
                                                                  A (control) 
where  A (control)      – Absorbance of the control 
            A (standard)   – Absorbance of the standard/extract 
Based on the values, a graph was plotted.  
 
7.3.1.2. Reducing power ability assay 
            The reducing power was determined according to the method of Oyaizu.60 Various 
concentrations of the plant extracts (1ml) were mixed with 1ml of 200mmol/l sodium 
phosphate buffer (pH 6.6) and 1ml of 1% potassium ferricyanide. The mixtures were 
incubated at 50˚C for 20 minutes. 1ml of 10% trichloroacetic acid (w/v) was added, the 
mixture was centrifuged at 2000rpm for 10 minutes. The upper layer solution (2.5ml) was 
mixed with 2.5ml of deionised water and 0.5ml of fresh ferric chloride (0.1%). The 
absorbance was measured at 700nm.  
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7.3.2. IN-VITRO HEPATOPROTECTIVE ACTIVITY BY MTT ASSAY USING 
NORMAL CHANG LIVER CELL LINE 
Materials and methods 
Plant extract 
 Hexane  
 Ethyl acetate 
 Ethanol  
Reagents  
 MEM – (Minimal Essential Media) purchased from Hi Media Laboratories 
 FBS – (Fetal bovine serum) purchased from Cistron laboratories 
 Trypsin, MTT – [3-(4,5-Dimethyl thiazol -2-yl) -2,5-diphenyl tetrazolium bromide] 
and DMSO ( Dimethyl sulfoxide) were purchased from Sisco research laboratory 
chemicals Mumbai. 
Cell line and culture 
 Normal chang liver cell lines were obtained from National Centre for Cell Sciences, 
Pune (NCCS). The cells were maintained in Minimal Essential Media supplemented 
with 10% FBS, penicillin (100 U/ml) and streptomycin (100µg/ml) in a humidified 
atmosphere of 50µg/ml CO2 at 37˚C. 
 Maintenance of cultures was passaged weekly and the culture medium was changed 
twice a week. 
Preparation of solutions 
Toxicants  
                100mg of paracetamol were dissolved in 10ml of DMSO and diluted to 100ml with 
minimum essential medium. 1000, 500, 250, 125, 62.5, 31.2, 15.6, 7.8 µg/ml solutions were 
prepared by diluting with distilled water. 
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Standard drug 
     100 mg of Silymarin were dissolved in 10ml of DMSO and diluted to 100ml with 
minimum essential medium. 1000, 500, 250, 125, 62.5, 31.2, 15.6, 7.8 µg/ml solutions were 
prepared by diluting with distilled water.   
Sample solutions  
     100mg of various extracts of test samples such as Hexane, Ethyl acetate and 
Ethanol were dissolved in 10ml of DMSO and diluted to 100ml with minimum essential 
medium. 1000, 500, 250, 125 62.5, 31.2, 15.6, 7.8 µg/ml solutions were prepared by diluting 
with distilled water. 
MTT assay 
Principle: 
            MTT assay is a standard colorimetric assay used for measuring the activity of the 
enzymes. It can also be used to determine cytotoxicity potential of medicinal agents and other 
toxic materials. 
            The assay is based on conversion of the MTT – [3-(4,5 – dimethyl thiazole -2-yl)-2,5- 
diphenyl tetrazolium bromide], a yellow tetrazole to a purple coloured formazan crystal by 
the active mitochondrial reductase (or cellular reductase) present in the viable cells. The 
purple colour thus formed is directly proportional to the viable cells present. This provides 
study of the cytotoxic activity of the test compounds. The absorbance of this coloured 
solution can be quantified by measuring at a wavelength of 500 to 600nm by 
spectrophotometer.  
Procedure: 
7.3.2.1. CYTOTOXICITY EVALUATION BY TETRAZOLIUM (MTT) ASSAY 61 
 The Chang liver monolayer cells were detached with Trypsin-ethylene Diamine tetra 
acetic acid (EDTA) to make single cell suspensions and the viable cells were counted 
using a haemocytometer and diluted with medium along with 5% FBS to give final 
density of 1×105cells/ml. 
 Cells (1×105/ well) were plated in 5ml of medium/well in 96 well plates (Coster 
Corning, Rochester, NY). 
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 After 48 hours incubation the cell reaches the confluence. Then, cells were incubated 
with different concentrations of Silymarin, Hexane, Ethylacetate and Ethanol, for 24-
48hrs at 37˚C. 
 After removal of the sample solution and washing with phosphate-buffered saline  
(pH 7.4), 1ml/well (5mg/ml) of 0.5% 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl- 
tetrazolium bromide cells (MTT) phosphate-buffered saline solution was added. 
 After 4 hours incubation, 0.04M HCl/ isopropanol were added. 
 Viability of  cells were determined by measuring the absorbance at 570nm using UV 
spectrophotometer and wells not containing sample were treated as blank.  
 Measurements were performed and the concentration required for a 50% inhibition of 
viability (IC50) was determined graphically. 
 Triplicate was maintained for all concentrations. 
 The effect of the samples on the proliferation of Chang Liver cells was expressed as 
the % cell viability, using the following: 
 
                    % cell viability = A 570 of treated cells ×100 
                                                             A 570 of control cells 
 
7.3.2.2. IN VITRO HEPATOPROTECTIVE ACTIVITY USING VARIOUS 
EXTRACTS AGAINST PARACETAMOL INDUCED HEPATOTOXICITY (MTT 
ASSAY) 62 
 The Chang liver monolayer cells were detached with trypsin-ethylene diamine tetra-
acetic acid (EDTA) to make single cell suspensions and viable cells were counted 
using a Haemocytometer and diluted with medium along with 5% FBS to give final 
density of 1×105 cells/ml. 
 Cells (1×105/well) were plated in 5ml of medium/well in 96 well plates (Costar 
Corning, Rochester, NY). 
 After 48 hours incubation the cell reaches the confluence. Then, cells were challenged 
with Hepatotoxicant (Paracetamol) 125µg/ml and different concentrations of various 
extracts (Hexane, Ethyl acetate and Ethanol) and the Standard drug (Silymarin) were 
added. The cells were incubated for 24- 48 hours at 37˚C. 
 After removal of the sample solution and washing with phosphate-buffered saline 
(pH-7.4), 1ml/well (5mg/ml) of 0.5% 3-(4,5- dimethyl -2- thiazolyl)-2, 5-diphenyl-
terazolium bromide cells (MTT) phosphate – buffered saline solution was added. 
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 After 4 hours incubation, 0.04M HCl/ isopropanol was added. 
 The absorbance at 570nm was measured with a UV- Spectrophotometer. The wells 
without sample acted as blank. 
 Triplicate was maintained for all concentrations. 
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7.3.3.  IN-VIVO STUDIES 
Model – Paracetamol induced Hepatotoxicity in Wistar Albino rats 
Selection of the active extract 
 In the in vitro method, the ethyl acetate extract exhibited the high percentage of 
protection paracetamol induced Hepatotoxicity using Normal Chang liver cell line. 
 Hence ethyl acetate extract was selected for in vivo study. 
Materials and Methods 
Plant extract  
        Ethyl acetate extract of berries of Vitex agnus castus 
Drugs and chemicals 
 Paracetamol (South East Pharmaceuticals, India) 
 Silymarin (Sigma Aldrich) 
 Carboxymethyl cellulose 
Preparation of drug solutions  
           The paracetamol, ethylacetate extract and standard drug (Silymarin) were suspended in 
1% Carboxymethyl cellulose and used for the study. 
Animal selection and procurement 
              Healthy adult Wistar albino rats (weighing 100-150g) of either sex were procured 
from Animal Experimental Laboratory, Madras Medical College, Chennai-03. Approval from 
the Institutional Ethical Committee was obtained for carrying out the study (8/243/CPCSEA 
dated 22/11/13). 
              The procured animals were kept in a clean and dry, polycarbonate cages and 
maintained in a well-ventilated animal house. The temperature of experimental animal room 
was maintained at room temperature and the relative humidity was maintained at 50-60%. 
Lighting was maintained for 12hrs dark and 12hrs light. All the animals were kept in the 
cages for at least 5 days prior to dosing for acclimatization to the laboratory conditions. The 
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animals were fed with normal diet and water was given ad libitum. The animals were fasted 
overnight but allowed to access water initially before the start of the study. 
 
7.3.3.1. ACUTE ORAL TOXICITY STUDIES 63 
              The acute oral toxicity study was carried out for ethylacetate extract using OECD 
guidelines 423 (Organization of economic co-operation and development). A single dose of 
2000mg/kg p.o. was given and this was used as a starting dose. After oral administration, the 
animals were observed every 1 hour for 24 hours to assess the general behaviour and 
mortality. They were further observed for 72 hours for toxic symptoms and mortality of the 
animal. The flow chart in figure depicts the procedure adopted for this method. (Fig. 2) 
 
Fig. 2. Flow chart for acute toxicity studies 
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7.3.3.2. HEPATOPROTECTIVE ACTIVITY 
Experimental method 29,31,64 
MODEL: Paracetamol induced hepatotoxicity in Wistar albino rats 
Rats are divided into five groups consisting of 6 animals each. 
Table 1. Paracetamol induced hepatotoxicity in Wistar albino rats 
GROUPS  TREATMENT SCHEDULE 
Group 1 Normal control Normal food and water 
Group 2 Disease control Vehicle (water) followed by paracetamol(2g/kg) p.o 
single dose on 7th day 
Group 3 Standard control Silymarin (100mg/kg) p.o for 7 days + Paracetamol 
(2g/kg) p.o single dose on 7th day 
Group 4 Test group I Ethyl acetate extract 200mg/kg p.o for 7 days + 
Paracetamol (2g/kg) p.o single dose on 7th day 
Group 5 Test group II Ethyl acetate extract 400mg/kg p.o for 7 days + 
Parcetamol (2g/kg) p.o single dose on 7th day 
             
 On the 9th day of the experiment, the rats were fasted overnight and sacrificed by 
cervical dislocation method. The blood samples were collected by retro orbital puncture with 
glass capillary and allowed to clot and centrifuged for 15- 20 minutes at 2000 rpm and the 
serum collected was used for assay of marker enzymes SGOT, SGPT, ALP, total protein and 
total bilirubin. 
 Histopathology: 
            The abdomen was cut open and the liver was dissected out. A portion of liver tissue 
was taken in each group and was immediately put in 10% formasal (formalin diluted to 10% 
with normal saline) and then it was processed. 
           Sections were stained with Ehrlich’s haematoxylin and eosin to view the necrotic 
lesions of liver microscopically. 
 
                                                                                                Methodology 
 
Department of Pharmacognosy, COP, MMC. Page 40 
 
Statistical analysis:  
            Data were expressed as mean ± S.E.M. Statistical comparison between the groups 
were done by one way analysis of variance (ANOVA) followed by t test. p values < 0.05 
were considered significant.   
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8. RESULTS AND DISCUSSION 
8.1. PHARMACOGNOSTICAL STUDIES 
The results of Pharmacognostical studies are as follows: 
 
8.1.1. Macroscopical features: 
Berries  
Colour   - greenish black 
Shape     - round or ovoid 
Odour    - aromatic 
Taste      - bitter and aromatic 
Size        - 2 to 4mm in diameter 
Surface  - hairy 
 
 
       
Fig. 3. Vitex agnus-castus berries 
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8.1.2. Microscopical features  
Transverse section: 
            Epicarp is composed of polygonal cells with thickened walls and some cells have 
shown simple pits. The epidermis shows the presence of covering and glandular trichomes. 
Glandular trichome is composed of single celled stalk and a four celled head. Mesocarp 
consists of isodiametric parenchyma cells with pitted walls. Outer mesocarp cells are brown 
in nature. Small vascular bundles are arranged in a circle. Small brachysclerides are seen in 
innermost cell layers. The cells are pigmented near the endosperm region. Starch grains are 
present in the endosperm region. 
 
 
Ep – Epicarp, Mc – Mesocarp, Ec - Endocarp 
Fig. 4. T.S. of Vitex (4X) entire fruit 
 
Ec 
 Mc 
Ep 
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Ep – Epicarp, ct – covering trichome 
Fig. 5. Vitex fruit (40X) epicarp 
 
 
 
Ec – Endocarp, Bs – brachyscleride 
Fig. 6. Vitex fruit endocarp (40X) 
 
  ct 
Ep 
Ec 
   Bs 
                                                                          Results and discussion 
 
Department of Pharmacognosy, COP, MMC. Page 44 
 
 
 
 
Ep - Epicarp 
Fig. 7. Vitex fruit epicarp (40X) 
 
 
 
 
 
 
 
 
 
 Ep 
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Calyx: 
            Outer epidermis is composed of compactly arranged small polygonal cells, covering 
and glandular trichome. The covering trichomes consist of 1 to 4 cells and glandular 
trichomes consist of a very small unicellular stalk and a 4-celled glandular head. Stomata can 
also be seen on the outer epidermis. The inner epidermis is glabrous and composed of 
rectangular elongated cells with irregular cell walls. The inner epidermis shows sclerides in 
the longitudinal direction.  
 
 
i.ep - inner epidermis, o.ep – outer epidermis 
Fig. 8. T.S. of Calyx (4X) 
 
 
 
 
i.ep 
o.ep 
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8.1.3. Powder microscopy: 
The powder microscopy showed the presence of mesocarp cells with starch grains, 
unicellular covering trichomes, xylem vessels, cortical parenchyma cells, brachysclerides, 
collenchyma cells and epicarp which are shown in the figures below. 
 
 
Fig. 9. Mesocarp cells with starch grains 
 
 
 
 
Fig. 10.Unicellular covering trichomes  
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Fig. 11. Xylem vessels 
• Xylem – thickening of vascular elements 
• Mesocarp showing cortical parenchyma with pigments 
 
 
 
bs – brachysclerides 
Fig. 12. Cellular contents with parenchyma cells 
 
 
 
bs 
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Fig.  13. Parenchyma cells with lignified cells 
 
 
 
 
 
 
 
Fig. 14. Collenchyma with thickened wall 
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Fig. 15. Ep - Epicarp  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    Ep 
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8.1.4. Physicochemical constants 
The physicochemical studies of the berries of Vitex agnus-castus showed the 
following results (Table 2,3,4): 
 
Table 2. Physicochemical constants- ash values 
S.No. ASH VALUES %W/W 
1. Total ash  10.55±0.69 
2. Water soluble ash 5.2±0.16 
3. Acid insoluble ash 3.4±0.17 
4.  Sulphated ash 12.48±0.18 
Values are expressed as Mean ± S.E.M. (n=3) 
   The total ash, water soluble ash, acid insoluble and sulphated ash of the berries of 
Vitex agnus-castus were found to be 10.55±0.69, 5.2±0.16, 3.4±0.17 and 12.48±0.18 
respectively. 
 
 
Table 3. Physicochemical constants- extractive values 
S.No. EXTRACTIVE VALUES %W/W 
1. Alcohol soluble extractive value 10.86±0.75 
2. Water soluble extractive value 14.8±0.72 
3. Non-volatile ether soluble extractive value 4.6±1.04 
4. Volatile ether soluble extractive value 3.5±0.50 
Values are expressed as Mean ± S.E.M.(n=3) 
The alcohol soluble extractive and water soluble extractive were found to be 
10.86±0.75 and 14.8±0.72. Non-volatile and volatile ether soluble extractives were found to 
be 4.6±1.04 and 3.5±0.50 respectively. 
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Table 4. Physicochemical constants 
S.No. PHYSICO-CHEMICAL CONSTANT %W/W 
III Loss on drying 3.73±1.10 
IV Foaming index <100 
V Swelling index Nil 
Values are expressed as Mean ± S.E.M. (n=3) 
 The loss on drying was found to be 3.73±1.10 and foaming index was less 
than 100. Swelling index was nil. 
 
8.1.5. Qualitative analysis of inorganic elements and heavy metal analysis 
The chemical studies on the powder showed the presence of several inorganic 
elements which tabulated in Table 5. 
Table 5. Qualitative analysis of inorganic elements of Vitex agnus-castus 
S.No. INORGANIC 
ELEMENTS 
REPORT 
1. Aluminium + 
2. Arsenic  + 
3. Boron - 
4. Calcium + 
5. Carbonate - 
6. Chlorides - 
7. Copper + 
8. Iron + 
9. Lead + 
10. Magnesium + 
11. Sulphate  + 
12. Nitrate - 
13. Phosphate - 
14. Potassium + 
+ indicates presence, - indicates absence 
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The qualitative analysis showed the presence of copper, calcium, magnesium, 
potassium, aluminium, iron. The quantitative estimation of inorganic elements were carried 
out and tabulated in Table 6. 
Table 6. Quantitative estimation of inorganic elements of Vitex agnus-castus 
 
          
 
 
 
 
  
8.1.6. Heavy metal analysis of Vitex agnus-castus 
            The quantification of the individual heavy metals was performed for the powdered 
berries of Vitex agnus-castus by ICP-OES technique given in Table 7.  
 
Table 7. Heavy metal analysis of Vitex agnus-castus 
S.No. INORGANIC ELEMENTS OSERVATION 
IN ppm 
STANDARD 
LIMITS(ppm) 
1. Arsenic 0.008 5 
2. Cadmium 0.004 0.3 
3. Lead 0.020 10 
4. Iron 0.057 10 
 
The study showed that the heavy metals arsenic, cadmium, lead and iron were well 
within the standard permitted limits of WHO. 
 
S.No. INORGANIC ELEMENTS TOTAL 
AMOUNT ppm 
1. Copper  0.185 
2. Calcium 0.261 
3. Magnesium 0.049 
4. Potassium 0.125 
5. Aluminium  0.145 
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8.2. PHYTOCHEMICAL STUDIES: 
8.2.1. Percentage yield of successive solvent extraction of berries of Vitex agnus-castus. 
Extraction was carried out with solvents of increased polarity for the berries of Vitex 
agnus-castus and percentage yield was determined and tabulated (Table 8).  
Table 8. % yield of successive solvent extraction of berries of Vitex agnus-castus. 
S.NO. EXTRACTS METHOD OF 
EXTRACTION 
PHYSICAL 
NATURE 
COLOUR % 
YIELD 
(W/W) 
1. Hexane Continuous hot 
percolation 
Semi-solid Pale green 8.4 
2. Ethyl acetate Sticky Greenish black 17.2 
3. Ethanol Semi-solid Brownish black 11.4 
 
The percentage yield of ethyl acetate extract was more compared to the other extracts. 
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8.2.2. Preliminary phytochemical screening on the berries of Vitex agnus-castus 
           Qualitative phytochemical analysis for the powder and various extracts of the berries 
of Vitex agnus-castus was performed. The results are given in Table 9. 
 
Table 9. Preliminary phytochemical screening on the berries of Vitex agnus-castus 
S.No. PHYTOCONSTITUENTS POWDER HEXANE 
EXTRACT 
ETHYL 
ACETATE 
EXTRACT 
ETHANOL 
EXTRACT 
1. Carbohydrates + - + + 
2. Flavonoid + - + + 
3. Glycosides + - + - 
4. Alkaloid + - + + 
5. Saponin + - + - 
6. Phytosterols + + - - 
7. Phenolic compounds + - + + 
8. Proteins - - - - 
9. Fixed oils and fats - - - - 
10. Tannins + - + - 
11. Triterpenoids + + + + 
12. Gums and mucilage - - - - 
+ indicates presence, - indicates absence 
The hexane extract of the berries showed the presence of phytosterols and 
triterpenoids. The ethyl acetate extract revealed maximum number of active constituents such 
as carbohydrates, flavonoids, glycosides, alkaloids, saponins, phenolic compounds, tannins 
and triterpinoids. The ethanol extract showed the presence of carbohydrates, flavonoids, 
alkaloids, phenolic compounds and triterpenoids.  
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8.2.3. Quantitative estimation of phytoconstituents 
Total flavonoid content: The absorbance of the standard quercetin at different 
concentrations and the absorbance of ethyl acetate and ethanol were found out and tabulated 
in Table 10.  
Table 10. Absorbance of quercetin, ethyl acetate & ethanol 
QUERCETIN  
CONCENTRATION 
(mg/ml) 
ABSORBANCE 
20 0.15 
40 0.22 
60 0.28 
80 0.36 
100 0.47 
 
Ethyl acetate 0.34 
Ethanol 0.31 
 
 
 
 
Fig. 16. Calibration curve of standard quercetin 
The concentration of Flavonoid present in Ethyl acetate extract was found to be 
92.66µg equivalent to Quercetin in 1mg(9.3%) and in Ethanol extract was found to be 8µg 
equivalent to Quercetin in 1mg(8%). The ethyl acetate extract was found to have higher 
amount of flavonoid than ethanol extract. 
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Total Phenol content: The absorbance of the standard gallic acid at different concentrations 
and the absorbance of ethyl acetate and ethanol were found out and tabulated in Table 11.  
Table 11. Absorbance of gallic acid, ethyl acetate & ethanol 
GALLIC ACID 
CONCENTRATION 
(mg/ml) 
ABSORBANCE 
2 0.05 
4 0.08 
6 0.12 
8 0.17 
10 0.22 
 
Ethyl acetate 0.19 
Ethanol 0.13 
 
 
 
Fig. 17. Calibration curve of standard gallic acid 
           The concentration of phenol present in Ethyl acetate extract was found to be 9µg 
equivalent to Gallic acid in 1mg(0.9%) and in Ethanol extract was found to be 6.12µg 
equivalent to Gallic acid in 1mg(0.61%). The ethyl acetate extract was found to have higher 
amount of phenols than ethanol extract. 
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8.2.4. Fluorescence analysis  
The fluorescence analysis of powdered drug and various extract of Vitex agnus-castus are 
tabulated in Table 12. 
Table 12. Fluorescence analysis of powder of Vitex agnus-castus. 
S.No. POWDERED DRUG DAY LIGHT UV LIGHT 
SHORT LONG 
1. Powder  Greenish brown Dark brown Brown 
2. Powder +water Light brown Brownish green Dark brown 
3. Powder +1N HCl Light brown Brownish black Brown 
4. Powder +1N H2SO4 Brownish black Reddish black Light brown 
5. Powder +1N HNO3 Pale brown Reddish green Yellowish green 
6. Powder +CH3COOH Brown Reddish brown Pale green 
7. Powder +1N NaOH Green Reddish brown Pale green 
8. Powder +alc.NaOH Greenish brown Greenish black Green 
9. Powder +1N KOH Green Greenish brown Green 
10. Powder +alc.KOH Brownish green Reddish brown Pale green 
11. Powder +NH3 Greenish yellow Green Brownish red 
12. Powder +I2 Green Reddish green Brownish green 
13. Powder +FeCl3 Pale brown Greenish black Greenish brown 
14. Powder +ethanol Light brown Greenish black Greenish brown 
 
Table 13. Fluorescence analysis of the various extracts of Vitex agnus-castus. 
S.No. EXTRACTS DAYLIGHT UV LIGHT 
SHORT LONG 
1. Hexane Pale green Reddish brown Green  
2. Ethyl acetate Greenish black Black Light brown 
3. Ethanol  Brownish black Brownish black Light brown 
 
No characteristic fluorescence was observed in powdered sample as well the extracts. 
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8.2.5. Thin layer chromatography 
Since the both the ethyl acetate and ethanol extract showed the presence of flavonoids 
and alkaloids, TLC was carried out with mobile phases for these two phytoconstituents and 
detected under UV chamber. 
Table 14. TLC of Flavonoids 
EXRTACTS SOLVENT SYSTEM NO.OF SPOTS RF VALUE 
Ethyl acetate Ethyl acetate: formic acid: 
glacial acetic acid: water 
(100:11:11:27) 
2 0.36 (spot 1) 
0.61 (spot 2) 
Ethanol 2 0.32 (spot 1) 
0.54 (spot 2) 
 
The ethylacetate extract showed two spots with Rf value 0.36 and 0.61. The ethanol 
extract also showed two spots with Rf value 0.32 and 0.54. Fig.18.1, 18.2 
 
 
                             
                           Ethyl acetate extract                              Ethanol extract            
Fig. 18.1-18.2 TLC of flavonoids 
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Table 15. TLC of Alkaloids 
EXTRACTS SOLVENT SYSTEM NO.OF SPOTS RF VALUE 
Ethyl acetate  
Toluene: ethyl acetate: 
diethyl amine (70:20:10) 
2 0.45 (spot 1) 
0.63 (spot 2) 
Ethanol 2 0.42 (spot 1) 
0.60 (spot 2) 
 
The ethylacetate extract showed two spots with Rf value 0.45 and 0.63. The ethanol 
extract also showed two spots with Rf value 0.42 and 0.60. Fig.19.1, 19.2 
 
                                     
                          Ethyl acetate extract                                 Ethanol extract 
Fig. 19.1-19.2 TLC of alkaloids 
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8.2.6. High performance thin layer chromatography 
TLC was run for the ethyl acetate before performing the HPTLC (Fig. 19). 
 
Fig. 20. TLC of Ethyl acetate extract 
Ethyl acetate: hexane :: 6:4 
TLC showed the presence of two spots.  
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Fig. 21. HPTLC chromatogram
 
 
 
Table 16. Rf values and area of ethyl acetate extract of 
 
S. No. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
              
The HPTLC chromatogram shows the presence of 11 peaks with their corresponding 
area and this indicates the presence of a number of phytoconstituents in the Ethyl acetate 
extract.  
                     Results and discussion
 MMC. 
 of ethyl acetate extract of Vitex agnus-
Vitex agnus
Rf HEIGHT AREA LAMBDA 
0.02 41.5 718.9 278 
0.06 9.0 78.9 273 
0.07 7.2 75.3 253 
0.11 2.6 27.8 379 
0.13 3.3 58.3 400 
0.19 6.0 127.0 294 
0.21 8.9 259.4 293 
0.29 2.2 44.7 288 
0.42 6.5 256.8 294 
0.58 35.6 2352.2 253 
0.69 1.3 39.4 356 
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8.3. PHARMACOLOGICAL STUDIES 
8.3.1. ANTI OXIDANT ACTIVITY 
8.3.1.1. Hydrogen peroxide scavenging method: The percentage inhibition of the standard 
and the various extracts were found out and tabulated in Table 17. 
Table 17.  H2O2 scavenging method 
 
S. 
No. 
 
CONCENTRATION 
µg/ml 
% INHIBITION 
STANDARD 
(ASCORBIC 
ACID) 
ETHYL 
ACETATE 
EXRTACT 
ETHANOL 
EXTRACT 
HEXANE 
EXTRACT 
1. 10 13.54 13.35 12.89 9.12 
2. 20 26.79 25.95 24.72 22.35 
3. 30 48.93 47.76 46.91 43.67 
4. 40 59.21 58.89 57.54 48.53 
5. 50 71.36 69.45 62.53 57.35 
 
 
 
Fig. 22. H2O2 scavenging assay 
 IC50 values were found to be: 
Standard (Ascorbic acid) - 33.53µg/ml, Ethyl acetate extract - 34.02µg/ml, Ethanol 
extract - 36.03µg/ml and Hexane extract - 40.30µg/ml.  
From the results it is clear that the ethyl acetate extract shows the most potent 
antioxidant activity compared to the other two extracts. The IC50 value of the ethyl acetate 
extract is equivalent to that of the standard drug Ascorbic acid. 
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8.3.1.2. Reducing power ability assay: The percentage inhibition of the standard and the 
various extracts were found out and tabulated in Table 18. 
Table 18. Reducing power ability assay 
 
S. No. 
 
CONCENTRATION 
(µg/ml) 
% INHIBITION 
STANDARD 
(ASCORBIC 
ACID) 
ETHYL 
ACETATE 
EXTRACT 
ETHANOL 
EXTRACT 
HEXANE 
EXTRACT 
1. 10 14.17 13.95 13.12 12.45 
2. 20 27.56 25.86 25.67 22.89 
3. 30 49.53 48.75 47.34 42.73 
4. 40 60.27 59.12 53.62 49.12 
5. 50 72.31 70.45 68.45 57.91 
 
 
 
Fig. 23. Reducing power ability assay 
IC50 values were found to be: 
             Standard (Ascorbic acid) - 33.53µg/ml, Ethyl acetate extract - 34.02µg/ml, Ethanol 
extract - 36.03µg/ml and Hexane extract - 41.09µg/ml. 
From the results it is clear that the ethyl acetate extract shows the most potent 
antioxidant activity compared to the other two extracts. The IC50 value of the ethyl acetate 
extract is equivalent to that of the standard drug Ascorbic acid. 
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8.3.2. In vitro studies: 
8.3.2.1. Cytotoxicity evaluation by tetrazolium (MTT) assay 
              The cytotoxicity studies were carried out for the standard silymarin and different 
extracts of the berries of Vitex agnus- castus on the Chang liver cell line over different 
concentration range (1000, 500, 250, 125, 62.5, 32.2, 15.6, 7.8µg/ml) and its CTC50 value was 
found out.(Table 19)  
Table 19. Cytotoxicity studies 
S.No. CONCENTRATION 
(mg/ml) 
% CELL VIABILITY 
SILYMARIN HEXANE 
EXRTACT 
ETHYL 
ACETATE 
EXTRACT 
HEXANE 
EXTRACT 
1. 1000 6.77 15.25 11.86 8.47 
2. 500 18..64 25.42 22.03 18.64 
3. 250 32.20 35.59 33.89 32.20 
4. 125 40.67 42.37 44.06 40.67 
5. 62.5 51.84 47.45 50.84 48.15 
6. 31.2 69.49 54.23 62.71 57.62 
7. 15.6 79.66 62.71 76.27 71.18 
8. 7.8 89.83 69.49 88.13 83.05 
9. Cell control 100 100 100 100 
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Fig. 24. Cytotoxicity of different extracts on Chang cell line 
         The cell viability decreased with increase in concentration of the test compounds. The 
CTC50 values of the extracts were found to be 62.5µg/ml which is similar to that of the 
standard silymarin thus proving that the extracts have no toxicity against the normal cell line.  
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8.3.2.2. In vitro hepatoprotective activity using various extracts against Paracetamol 
induced hepatotoxicity : 
          The Chang liver cells were first challenged with the paracetamol at the concentration of 
125µg/ml in which 39.92% cells are viable. Then the cell line was treated with standard 
silymarin and different extracts of Vitex agnus-castus in the concentration of 100, 50, 25, 
10µg/ml to assess the percentage cell viability and the values are tabulated in Table 20. 
Table 20. In vitro hepatoprotective activity 
S.No. TREATMENT CONCENTRATION 
Mg/ml 
% CELL 
VIABILITY 
1. Control  100 
2. Paracetamol 125 39.92±1.02 
3. Paracetamol 
+ 
Silymarin 
10 55.9±1.15 
25 60.4±1.04 
50 65.8±1.43 
100 71.3±1.09 
4. Paracetamol 
+ 
ethyl acetate extract 
10 49.8±1.24 
25 58.3±1.31 
50 62.5±1.57 
100 72.9±1.43 
5. Paracetamol 
+ 
Ethanol extract 
10 36.6±1.83 
25 47.9±1.26 
50 52.5±1.74 
100 58.7±1.89 
6. Paracetamol 
+ 
Hexane extract 
10 32.6±1.55 
25 41.3±1.21 
50 49.2±1.92 
100 57.1±1.34 
Values are expressed as Mean ± S.E.M. (n=3) 
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Fig. 25. In vitro hepatoprotective activity of different extracts using paracetamol 
induced toxicity 
 
               In the silymarin treated group, the cell viability was 73.1% at the highest 
concentration of 100µg/ml. The ethyl acetate extract showed significant increase in cell 
viability of 72.9% which is relatively close to that of the standard compared to the other two 
extracts. Hence ethyl acetate extract was selected for in vivo studies. 
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8.3.3. In vivo studies 
8.3.3.1. Acute oral toxicity studies 
             No toxic symptoms and mortality was observed when ethyl acetate extract was 
administered at the dose level of 2000mg/kg. Hence 1/10th and 1/5th of this dose (200 and 
400mg/kg) was taken for this study. 
8.3.3.2. Hepatoprotective activity 
Body weight 
             The animal body weight was calculated on 1st and 9th day of the study period and 
tabulated in Table 21. 
Table 21. Change in body weight 
TREATMENT GROUPS ANIMAL BODY WEIGHT IN gms 
1st day 9th day 
Group I-control 133.33±0.14 135.47±0.17 
Group II-disease control 138.33±0.48 136.04±0.35 
Group III- standard control 135.00±0.52 134.00±0.43 
Group IV-test group I 140.33±0.23 137.21±0.51 
Group V-test group II 130.00±0.12 128.00±0.25 
Values are expressed as Mean ±S.E.M. (n=6)  
 
Fig. 26. Change in body weight 
               The disease control group showed slight decrease in body weight compared to the 
treated groups. 
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Evaluation of biochemical parameters 
                The biochemical parameters such as SGOT, SGPT, ALP, total bilirubin and total 
protein were found out. (Table 22 and Fig.27) 
Table 22. Evaluation of biochemical parameters 
Biochemical 
parameters 
SGOT (U/L) SGPT (U/L) ALP (U/L) Total 
bilirubin 
(gm/dl) 
Total 
protein 
(gm/dl) 
Group I 55.35±0.12 51.67±0.09 27.42±0.13 0.60±0.001 7.16±0.001 
Group II 110.44±0.09 a 120.63±0.12 a 96.44±0.11 a 1.35±0.010 a 5.85±0.010 a 
Group III 60.52±0.13 ab 56.54±0.15 ab 35.48±0.09 ab 0.63±0.001ab 7.44±0.001ab 
Group IV 78.27±0.06 ab 68.45±0.13 ab 58.54±0.12 ab 0.74±0.001 ab 6.73±0.001 ab 
Group V 63.36±0.08 ab 61.69±0.10 ab 39.42±0.08 ab 0.65±0.001ab 7.82±0.001ab 
 
Values are expressed as Mean±S.E.M.   
Data were analysed by one way ANNOVA followed by Dunnett’s  t-test.  
‘a’ values were significantly different from normal control at P<0.01.  
‘b’ values were significantly different from disease control at P<0.01. 
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Fig. 27.1 Fig. 27.2 
 
  
Fig. 27.3 Fig.27.4 
 
 
Fig.27.5 
 
Fig. 27. Graphical representation of biochemical parameters 
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              Estimation of the liver enzymes (SGOT, SGPT, ALP and TB) showed that in the 
paracetamol challenged group, there was a significant (p<0.01) rise in the levels of these 
enzymes. This is an indicator for hepatotoxicity. In the silymarin treated group, the enzyme 
levels were significantly reduced (p<0.01). In the drug treated groups also there was a 
significant decrease in the enzyme levels. 
             There was significant decrease in total protein levels (TP) in disease control group 
compared to the normal control group. The decrease in TP level in hepatotoxicity is mainly 
due to the presence of para proteins or decreased antibody production. Extract 200mg/kg and 
400mg/kg treated groups showed significant (p<0.01) increase in TP level. This indicates that 
the extract, at both the doses tested, showed significant hepatoprotective activity. 
             Eventhough standard and extract treated groups were significantly different from 
control, the values were reduced when compared to disease control group. 
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Histopathological studies  
               Histopathological sections of various groups are
 
Fig.
            
GROUP 1- Normal control
GROUP 3- Standard control
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 shown in Fig. 28.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 28. Histopathological studies 
 
GROUP 2- Disease control
 
 
GROUP 4- Test drug 1
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             Histopathological studies reveal that liver shows normal hepatocellular arrangement 
in normal control group. The paracetamol treated group shows loss of hepatic architecture 
with intense peripheral central vein necrosis and crowding of central vein. A normal hepatic 
architecture with hepatic rearrangement is seen in the silymarin pre-treated group. Group 
treated with 200mg/kg of berries extract reduces the hepatic injury, showing mild degree of 
necrosis and group treated with 400mg/kg of the berries extract reduces hepatic injury and 
necrosis clearly indicating the protection offered by the drug.    
            The presence flavonoids, glycosides and alkaloids contribute to hepatoprotective 
activity in many plants. The presence of flavonoids such as quercetin in Phyllanthus 
emblica65, luteolin, apigenin in Equisetum arvense66, citromitin, tangeretin in Citrus 
depressa67, glycosides such as acubin from Plantago asiatica, picroside I and II from 
Picorrhiza kurroa68 and alkaloids such as steroidal alkaloids in Hygrophila auriculata69 
showed potent liver protecting activity. In this study, the berries of Vitex agnus-castus have 
been shown to be rich in flavonoids, glycosides and alkaloids. Hence, the hepatoprotective 
activity of Vitex agnus-castus may be due to the presence of these phytoconstituents. 
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9. SUMMARY AND CONCLUSION 
Vitex agnus-castus (Verbanaceae), generally called as the “women’s herb” has a long 
term tradition of being used as a complementary medicine in Europe and also has a folklore 
claim for treating enlarged liver. It is also reported to possess antioxidant activity which are 
known to enhance hepatoprotective activity. In the present study hepatoprotective activity on 
the berries of Vitex agnus-castus is reported. 
 The pharmacognostical studies revealed various distinguishing characters present in 
the plant. The morphological studies showed that berries are greenish black, round to ovoid in 
shape with hairy surface and has a aromatic odour and bitter taste. 
The microscopical sections of the berries showed the presence of polygonal cells 
with thickened cell walls, simple pits, covering and glandular trichomes in the epidermis 
of the epicarp. The mesocarp consists of isodiametric parenchyma cells and endocarp 
showed the presence of brachysclerides.   
The powder microscopy revealed the presence of starch grains, unicellular covering 
trichomes, xylem vessels, cortical parenchyma cells, brachysclerides and collenchymas 
cells. 
Standardisation of the drug was done by performing various physicochemical 
constants such as ash value, extractive values, loss on drying, foaming index and swelling 
index. The qualitative and quantitative estimation of the powdered drug was done which 
showed the presence of aluminium, calcium, copper, iron, magnesium, sulphate and 
potassium which were within the Pharmacopoeial limits. 
Extraction was carried out with solvents of increasing polarity for the berries of Vitex 
agnus-castus and the percentage yield of ethyl acetate extract was found to be more 
compared to the other extracts. 
Preliminary phytochemical screening of the extracts was performed. The hexane 
extract showed the presence of phytosterols and triterpenoids. The ethyl acetate extract 
revealed maximum number of active constituents such as carbohydrates, flavonoids, 
glycosides, alkaloids, saponins, phenolic compounds, tannins and triterpenoids. The 
ethanol extract showed the presence of carbohydrates, flavonoids, alkaloids, phenolic 
compounds and triterpenoids.  
                                                                     Summary and conclusion 
 
Department of Pharmacognosy, COP, MMC. Page 75 
  
Quantification of flavonoids and phenols were carried out. The concentration of 
flavonoid present in ethyl acetate and ethanol extract was found to be 92.66µg equivalent 
to Quercetin in 1mg(9.3%) and 8µg equivalent to Quercetin in 1mg(8%). The 
concentration of phenol present in ethyl acetate and ethanol extract was found to be 9µg 
equivalent to Gallic acid in 1mg(0.9%) and 6.12µg equivalent to Gallic acid in 
1mg(0.61%). 
The fluorescence analysis of powder and the various extracts were carried out and no 
fluorescence was observed. 
The chromatography was performed, in which the ethyl acetate and ethanol extract 
each showed two spots for flavonoid mobile phase with Rf value 0.36, 0.61, 0.32 and 0.54. 
For alkaloid mobile phase also two spots each observed for both the extracts with Rf value 
0.45, 0.63, 0.42 and 0.60. The HPTLC chromatogram of the ethyl acetate showed the 
presence of 11 peaks with their corresponding areas. 
The antioxidant activity was carried out by H2O2 scavenging method and reducing 
power ability assay. The IC50 value of the ethyl acetate extract in both the methods was 
found to be almost equivalent to that of the standard drug Ascorbic acid and showed the most 
potent antioxidant activity compared to the other two extracts.  
Toxicity studies on normal Chang liver cell line showed that all the extracts were non-
toxic. The in vitro hepatoprotective studies using paracetamol induced hepatotoxicity on 
Chang liver cell line showed that the ethyl acetate extract offered maximum protection 
against hepatotoxicity caused by paracetamol. The cell viability of the ethyl acetate and 
paracetamol treated group was 72.9% as against the cell viability of paracetamol treated 
group which was only 39.92%.   
The in vivo studies were performed using two doses (200 and 400mg/kg) of the ethyl 
acetate extract. Both the doses tested showed significant hepatoprotective activity indicating 
that the plant possesses hepatoprotective activity.  
This study substantiates our hypothesis that Vitex agnus-castus may be a useful 
hepatoprotective plant. Further studies on isolation of the phytoconstituents responsible for 
the activity are suggested.  
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